Community hub
0 subscribers7 pages, 0 posts
Recent from talks
All channels
Be the first to start a discussion here.
Be the first to start a discussion here.
Be the first to start a discussion here.
Be the first to start a discussion here.
Contribute something
Welcome to the community hub built to collect knowledge and have discussions related to Heliyon.
Nothing was collected or created yet.
Heliyon
View on Wikipediafrom Wikipedia
 | |
| Discipline | Multidisciplinary |
|---|---|
| Language | English |
| Publication details | |
| History | 2015–present |
| Publisher | |
| Frequency | Monthly |
| Yes | |
| License | CC BY |
| 3.4 (2023) | |
| Standard abbreviations | |
| ISO 4 | Heliyon |
| Indexing | |
| ISSN | 2405-8440 |
| OCLC no. | 934910176 |
| Links | |
Heliyon is a monthly peer-reviewed open-access mega journal covering research in science, medicine and engineering. Unlike most of its competitors, the journal will consider for publication works reporting negative/null results, incremental advances, and replication studies,[1] thus filling the market niche, which became vacant after the discontinuation of the Journal of Negative Results in Biomedicine in 2017.
Heliyon was established in 2015 by Cell Press, a division of Elsevier. According to the publisher's website: "the [journal's] name is all about shining light on important research. Helios was the Greek god of the sun. This root word gave us inspiration, as we want this journal to illuminate knowledge across a broad spectrum."[2]
The journal is divided into numerous sections, each with its own editorial team. Articles are published under a CC BY open access license.
Abstracting and indexing
[edit]The journal is abstracted and indexed in:
As of October 2024[update], the journal's indexation in the Science Citation Index Expanded is "on hold" and pending re-evaluation, with Web of Science citing the concerns on "the quality of the content published in this journal" as a reason for the suspension.[5][9]
References
[edit]- ^ "Cell Press: Heliyon".
- ^ "New open access journal Heliyon opens for submissions". www.elsevier.com.
- ^ "Serials cited". CAB Abstracts. CABI. Retrieved 2021-12-24.
- ^ "CAS Source Index". Chemical Abstracts Service. American Chemical Society. Retrieved 2024-10-12.
- ^ a b c d "Web of Science Master Journal List". Intellectual Property & Science. Clarivate . Retrieved 2021-12-24.
- ^ "Heliyon". Directory of Open Access Journals. Retrieved 2024-10-12.
- ^ "Heliyon". MIAR: Information Matrix for the Analysis of Journals. University of Barcelona. Retrieved 2021-12-24.
- ^ "Source details: Heliyon". Scopus Preview. Elsevier. Retrieved 2021-12-24.
- ^ Joelving, Frederik (September 30, 2024). "Web of Science puts mega-journals Cureus and Heliyon on hold". retractionwatch.com. Retraction Watch. Retrieved October 12, 2024.
External links
[edit]Heliyon
View on Grokipediafrom Grokipedia
History
Establishment
Heliyon was founded in 2015 by Cell Press, a division of Elsevier, to address the growing demand for a multidisciplinary open-access platform that publishes sound, scientifically rigorous research across all fields without the constraints of traditional disciplinary silos.[1][2] This initiative aimed to foster a community-driven publishing model emphasizing simplicity, openness, and technological integration to support researchers in sharing valuable findings efficiently.[2] The launch was announced on March 31, 2015, marking the opening of submissions for what was positioned as an innovative all-science journal.[2] The name Heliyon draws from Helios, the ancient Greek god of the sun, symbolizing the enlightenment and broad illumination of knowledge through accessible scientific dissemination.[2] The journal's initial organizational setup featured an in-house editorial team led by founding Editor-in-Chief Dr. Claudia Lupp, a pharmacologist with expertise in integrative biology, alongside editorial assistants Chris Russell and Marion Thibaudeau.[2] The editorial board was structured to prioritize multidisciplinary representation, with active recruitment of over 500 global experts to ensure diverse oversight in peer review processes.[2] Elsevier's broader strategic objectives for Heliyon centered on establishing a mega-journal model that values scientific accuracy and reproducibility above criteria like novelty or perceived impact, differentiating it from selective, high-impact outlets while allowing for experimental enhancements in the publishing workflow.[2] This approach sought to apply insights from Heliyon's operations to refine Elsevier's wider portfolio of journals.[2]Launch and Early Years
Heliyon officially launched on September 21, 2015, with the publication of its first eight original research articles spanning diverse disciplines from agriculture to zoology, signaling the journal's debut as an open-access mega-journal under Cell Press, a division of Elsevier.[5] This initial rollout followed the announcement earlier that year of Heliyon's intent to provide a platform for sound science across all fields, motivated by the need for a multidisciplinary venue that prioritizes scientific validity over novelty.[2] The journal adopted a monthly publication schedule from its inception, with Volume 1 (2015) featuring 29 articles in total.[6] In its early operational phase, Heliyon faced challenges typical of a new entrant in the competitive academic publishing landscape, particularly in establishing visibility and attracting submissions as a multidisciplinary open-access journal amid skepticism toward mega-journals.[7] Despite this, publication output began to ramp up steadily; Volume 2 (2016) saw continued monthly issues, contributing to the journal's initial growth, while it achieved a key milestone with inclusion in the Directory of Open Access Journals (DOAJ) in November 2016, enhancing its discoverability and credibility among researchers.[8] From 2017 to 2018, Heliyon experienced notable expansion in submission and publication volumes to accommodate its broadening multidisciplinary scope, with 268 articles published in 2017 and 593 in 2018, reflecting a more than doubling of output year-over-year.[9] This period marked the journal's transition from a cautious launch to a more established presence, supported by ongoing recruitment to its editorial board to manage the influx of diverse manuscripts across scientific domains.[10] In September 2024, Clarivate's Web of Science placed Heliyon on hold for indexing due to concerns over publication quality and integrity. This led to Elsevier retracting 74 papers from the journal by March 2025. As of November 2025, the hold remains in effect, with ongoing re-evaluation, impacting the journal's citation metrics and academic standing.[4][11]Scope and Editorial Policy
Disciplines Covered
Heliyon publishes research across a wide array of scientific fields, spanning physical sciences such as physics, chemistry, and earth sciences; life sciences including biology, ecology, plant biology, and animal science; medical sciences encompassing clinical research, pharmacology, oncology, and public health; applied sciences like engineering, materials science, and computer science; and social sciences such as psychology, economics, and education.[12][13] The journal's scope is intentionally broad and multidisciplinary, with an emphasis on interdisciplinary work that bridges traditional boundaries, provided the research is scientifically rigorous and contributes meaningful insights.[12] Submissions are considered from the physical, applied, life, social, and medical sciences, excluding arts, humanities, and law, as long as they demonstrate sound methodology and value to the relevant field.[12] In 2023, Heliyon introduced a dedicated Business and Management section to accommodate research in economics, organizational studies, finance, and related areas, further expanding its coverage of social and applied sciences.[14][13] Representative article topics illustrate this diversity, from climate modeling and environmental impact assessments in earth sciences to behavioral experiments and psychological interventions in social sciences.[13] The peer review process is applied uniformly across all disciplines to ensure consistent standards.[12]Peer Review Process
Heliyon employs a single anonymized (single-blind) peer review process by default, in which reviewers are aware of the authors' identities but authors do not know the reviewers' identities. Authors may request a double-anonymized review option during submission, ensuring neither party knows the other's identity.[10][15] The review process commences with an initial editorial assessment to evaluate the manuscript's suitability for the journal and its basic scientific accuracy. Manuscripts passing this stage are assigned to a minimum of two independent expert reviewers selected from a global pool of specialists in the relevant field. Reviewers assess the submission for scientific rigor, reproducibility of methods, accuracy of data, appropriate acknowledgment of prior work, and overall value to the research community, with emphasis placed on soundness rather than novelty or potential impact. Handling editors synthesize the reviewer reports to render the final decision on acceptance, revision, or rejection, potentially involving one or more revision rounds. Reviewers are requested to submit their reports within 14 days, with extensions available upon request.[10][15] Median timelines indicate 16 days from submission to the first editorial decision and 72 days to a decision following peer review. Rejection decisions are grounded in the manuscript's scientific validity and adherence to ethical standards, ensuring only reproducible and accurate research advances to publication.[1] Special issues follow the same peer review protocol as regular submissions, with guest editors providing advisory input but recusing from final decision-making to maintain impartiality. Conflicts of interest are managed by having editors recuse themselves from handling related manuscripts, which are then overseen by alternative team members in confidence; reviewers must similarly decline invitations if personal, professional, or financial conflicts arise. Rejected authors may appeal through the Journal Article Publishing Support Center, where the original handling editor issues the final ruling.[10][15] This process is applied uniformly across all scientific disciplines to uphold consistent quality standards.[10]Publication Model
Open Access Structure
Heliyon operates as a fully gold open access journal, meaning all accepted articles are immediately and permanently available for readers to access, read, download, and reuse without subscription barriers or paywalls upon publication.[16] This model ensures that content is freely accessible on both the journal's website (Heliyon.com) and Elsevier's ScienceDirect platform, with no embargoes imposed, thereby supporting broad dissemination and perpetual open access.[16] To sustain this open access structure, Heliyon levies an Article Processing Charge (APC) of $2,270 USD (excluding taxes) as of 2025, which is payable upon manuscript acceptance.[17] The APC covers the costs associated with editorial handling, peer review management, production (including formatting and typesetting), and long-term hosting and archiving of articles.[16] Authors retain copyright but grant the journal rights to publish under an open license, with options including Creative Commons Attribution (CC BY) 4.0, CC BY-NonCommercial (CC BY-NC) 4.0, or the default CC BY-NonCommercial-NoDerivatives (CC BY-NC-ND) 4.0, allowing varying degrees of reuse while protecting author interests.[16] Heliyon provides support for equitable access through waiver and discount programs. Full waivers are automatically applied for corresponding authors affiliated with institutions in low- and middle-income countries eligible under the Research4Life program, which aims to bridge the global research divide.[16] Additionally, institutional agreements negotiated with Elsevier offer reduced or waived APCs for affiliated researchers, depending on the partnership terms.[18] The journal's open access model aligns with major funder policies, including compliance with cOAlition S's Plan S requirements for immediate open access without embargoes, as well as mandates from organizations like the National Institutes of Health (NIH) and the Wellcome Trust, ensuring that funded research meets accessibility standards.[19] This structure facilitates integration with peer-reviewed content across disciplines while prioritizing unrestricted global reach.[16]Article Types and Formatting
Heliyon accepts a variety of article types to accommodate diverse scientific contributions, with a focus on scientifically accurate and valuable research across disciplines. The primary types include original research articles, which report study outcomes such as positive, negative, incremental advances, or replications; reviews, which may be invited or unsolicited and encompass narrative, literature, scoping, systematic, or meta-analytic approaches; and short communications, designed for concise reports of novel findings with broad interest.[10] These types undergo the journal's peer review process to ensure rigor.[10] Original research articles are structured in the IMRAD format—Introduction, Methods, Results, and Discussion—to clearly present the study's rationale, procedures, findings, and implications—while reviews typically include an abstract, main body synthesizing existing literature, and conclusions. There are no strict page or word limits for any article type, allowing flexibility in length, though the journal emphasizes conciseness to maintain readability and focus. Manuscripts must include 4–8 keywords in English and an abstract of up to 300 words, which should be structured (e.g., background, methods, results, conclusions) where appropriate for the field, serving as a standalone summary without abbreviations unless standard.[10] Authors are provided with Word or LaTeX templates to guide preparation, and initial submissions require no special formatting beyond editable files (e.g., .docx or .tex).[10] Figures and tables are integrated directly into the online publication on ScienceDirect, with no limits on quantity; they must be numbered sequentially, accompanied by detailed captions, and uploaded in high-resolution, editable formats such as JPEG or Excel. Supplementary materials, including unlimited datasets, videos, or additional analyses, are hosted separately on the platform and referenced in the main text with concise captions to support transparency. Ethical standards require data availability statements detailing access to underlying data, and declarations of ethics approval, informed consent for human or animal studies, and adherence to guidelines like ICMJE recommendations and ARRIVE for animal research. ORCID iDs are recommended for all authors.[10] All submissions are handled through the Editorial Manager platform, where authors upload files, cover letters (optional unless double-anonymized review is requested), and title pages with affiliations and corresponding author details.[10]Impact and Metrics
Citation Indicators
Heliyon's Impact Factor, as reported in the 2025 Clarivate Journal Citation Reports release, stands at 3.6, representing the average number of citations received by articles published in the journal during the preceding two years.[1] The 5-year Impact Factor is 3.9, providing a longer-term view of citation influence by averaging citations to articles from the previous five years.[20] Additional metrics from Scopus highlight Heliyon's standing in the multidisciplinary sciences category. Its CiteScore is 4.1, calculated as the average citations per document over a four-year period, while the SCImago Journal Rank (SJR) is 0.644, placing it in the Q1 quartile for Multidisciplinary Sciences based on weighted citations and journal prestige.[6] The journal's H-index of 115 indicates that 115 articles have each received at least 115 citations, underscoring sustained scholarly impact across its publication history.[6] Heliyon's publication volume has expanded dramatically, reflecting its role as a high-output open access platform. In 2016, it published approximately 500 articles, but by 2025, annual output exceeded 10,000, with 17,760 articles in 2024 alone and continued growth into 2025.[21] This scaling supports broad dissemination but influences citation dynamics due to the large denominator in average metrics. Citation trends for Heliyon show steady growth since its initial Impact Factor assignment around 2019 (approximately 2.0), reaching a peak of 4.45 in 2022 before stabilizing near 3.6-4.3 in subsequent years through 2025.[22] This pattern aligns with increasing visibility in an expanding corpus, though recent Clarivate scrutiny on content quality has prompted a temporary "on hold" status for some indexing evaluations.[4]| Metric | Value (2025) | Source |
|---|---|---|
| Impact Factor | 3.6 | Clarivate JCR[1] |
| 5-Year Impact Factor | 3.9 | Clarivate JCR[20] |
| CiteScore | 4.1 | Scopus[23] |
| SJR | 0.644 (Q1) | SCImago[6] |
| H-Index | 115 | SCImago/Scopus[6] |